IV wellness supplement (unlicensed NAD+ injectable)
NAD+ at-home IV drip consumable vial
Certifications
NAD+ injectable supplements, including NAD+ AT HOME products, are described in independent UK commentary as not licensed by the MHRA for medical use and therefore not approved medicines on the NHS; they are supplied as wellness or food Supplement Type products rather than authorised medicinal products.
No UK MHRA product licence (PL number), CE/UKCA medical device registration, or EMA/HPRA regulatory assessment specific to NAD+ AT HOME injectable vials is publicly available.
NAD+ injectable supplements, including NAD+ AT HOME products, are described in independent UK commentary as not licensed by the MHRA for medical use and therefore not approved medicines on the NHS; they are supplied as wellness or food Supplement Type products rather than authorised medicinal products.
No UK MHRA product licence (PL number), CE/UKCA medical device registration, or EMA/HPRA regulatory assessment specific to NAD+ AT HOME injectable vials is publicly available.
FacesConsent, the platform listing NAD+ AT HOME x1 vial and related NAD+ products, promotes itself as an MHRA Licensed broker, but this relates to its role as a medicines broker generally and does not constitute MHRA licensing of this specific NAD+ supplement as a medicinal product.
Description
NAD+ AT HOME x1 vial is an at-home intravenous (IV) wellness supplement supplied as a single powdered NAD+ vial, sold via The Crystal Pharmacy through the FacesConsent platform under the IV Drips [Consumables] category. The product is described as a unique supplement solution for people looking to boost performance and overall well-being, formulated to address age-related declines in NAD+ (nicotinamide adenine dinucleotide) levels that may reduce optimal cellular function. According to the seller description, supplementing with NAD+ at home is promoted as a way to help replenish NAD+ levels, enhance cellular health and vitality, support natural defences, optimise performance, and promote youthful vitality. The vial is explicitly labelled for IV use only and is intended to be used as part of IV treatment regimens arranged and supervised by a prescriber, rather than as an over-the-counter oral supplement.
Bnefits
Described as a unique NAD+ supplement solution for those looking to boost performance and well-being.
Marketed to help replenish declining NAD+ levels associated with ageing and sub-optimal cellular function.
Promoted to enhance cellular health and vitality by supporting cellular energy metabolism.
Marketed benefits include helping to replenish energy and reduce fatigue.
Aims to support natural defences and optimise physical and cognitive performance according to product literature.
Promoted as supporting youthful vitality and healthy ageing when used as part of an IV wellness protocol.
Supplied as an at-home IV product through a GPhC-registered aesthetic pharmacy for practitioner-supervised use.
Indications
Marketed for adults seeking to boost performance and overall well-being via IV NAD+ supplementation.
Promoted for individuals wishing to support cellular health, energy and vitality as part of wellness or longevity-focused IV therapy.
Sold through an aesthetic pharmacy and IV drips consumables category for use in clinic or at-home IV protocols arranged by a prescriber.
Not a licensed medicinal product and not indicated for the treatment or prevention of specific diseases in official regulatory documentation.
FacesConsent, the platform listing NAD+ AT HOME x1 vial and related NAD+ products, promotes itself as an MHRA Licensed broker, but this relates to its role as a medicines broker generally and does not constitute MHRA licensing of this specific NAD+ supplement as a medicinal product.
The Crystal Pharmacy is a GPhC Registered UK pharmacy supplying aesthetic and wellness products to practitioners; its regulatory status as a pharmacy does not imply MHRA approval of this specific NAD+ x1 vial as a medicine.
The Crystal Pharmacy is a GPhC Registered UK pharmacy supplying aesthetic and wellness products to practitioners; its regulatory status as a pharmacy does not imply MHRA approval of this specific NAD+ x1 vial as a medicine.
NAD+ at-home IV drip consumable vial
Composition
Active ingredient: Nicotinamide adenine dinucleotide (NAD+), described in associated brand and platform materials as a derivative of vitamin B3 and a key cellular coenzyme.
Exact NAD+ strength (mg per vial), excipients, pH, osmolality and reconstitution details for this specific x1 IV vial presentation are not publicly listed by The Crystal Pharmacy, FacesConsent or NAD+ AT HOME.
The FacesConsent listing states the product is a supplement that comes in powdered form intended for IV use after appropriate reconstitution, but does not provide a full qualitative or quantitative composition.
No publicly accessible SmPC, technical data sheet (TDS) or safety data sheet (SDS) specific to this vial has been found.
Formulation
Dosage form: Powder in a single vial intended for reconstitution for intravenous (IV) administration.
The FacesConsent product description states that NAD+ AT HOME "comes in powdered form" and is labelled "FOR IV USE ONLY".
Coenzyme type: NAD+ (nicotinamide adenine dinucleotide), a vitamin B3 derivative coenzyme, used here as an injectable wellness supplement rather than a licensed medicinal formulation.
Detailed formulation parameters (concentration after reconstitution, diluent type, osmolarity, preservative status, sterility assurance) are not publicly listed for this specific x1 vial product.
Packaging
Pack size: x1 vial – listed as "NAD+ AT HOME x1 vial" supplied individually.
Product category on FacesConsent: IV Drips → IV Drips [Consumables], sold by The Crystal Pharmacy.
Visual materials show an amber glass-style vial with stopper and cap bearing the NAD+ AT HOME branding; however, precise packaging specifications (vial material, closure system, carton labelling, tamper-evidence) are not publicly described.
No information is publicly listed regarding secondary packaging, leaflet inclusion or outer carton dimensions and materials.
Usage
Labelled and described as "FOR IV USE ONLY" on the FacesConsent listing.
Marketed as an IV supplement to be used as part of NAD+ AT HOME at-home or clinic IV protocols under prescriber supervision; purchasing via FacesConsent requires a connected prescriber to process prescription items.
The description emphasises use in IV treatment to replenish NAD+ levels and enhance cellular health and vitality, but does not provide specific directions on reconstitution, infusion rate, dosing schedule or maximum dose.
No official step-by-step preparation or administration instructions for this specific x1 vial product are publicly listed; practitioners are expected to follow their own clinical protocols and any instructions provided directly by the brand or pharmacy.
Patients and practitioners are advised, by general NAD+ wellness guidance and platform messaging, not to self-administer IV products without appropriate medical oversight; however, concrete protocol details are not disclosed publicly for this vial.
Because NAD+ injectable products are not MHRA-licensed medicines, there is no publicly available UK SmPC or PIL giving standardised dosing information for this specific product.
Contraindications
Not publicly listed for this specific NAD+ AT HOME x1 IV vial product.
No official contraindication list (e.g. hypersensitivity, specific comorbidities, pregnancy, renal or hepatic impairment) is published in public-facing materials for this product.
Users are generally advised in broader NAD+ wellness discussions to seek medical assessment before IV NAD+ therapy, especially if they have underlying medical conditions, but no product-specific contraindication statement is provided.
Adverse Effects
Not publicly listed for this specific NAD+ AT HOME x1 IV vial product.
No product-specific adverse reaction profile, frequency table, or safety section equivalent to an SmPC is available from The Crystal Pharmacy, FacesConsent or NAD+ AT HOME for this exact vial.
General wellness and media sources discuss potential side effects of IV NAD+ (e.g. nausea, flushing, discomfort during infusion), but these are not formally listed as adverse reactions for this product and therefore are not included as product-specific safety information.
Storage Conditions
Not publicly listed for this specific x1 IV vial product.
No labelled storage temperature range, light protection requirements, shelf life, or in-use stability information following reconstitution is provided in publicly available materials for this vial.
Standard pharmacy practice would usually require compliance with storage instructions on the pack or from the supplier, but those details are not accessible from public online sources.
